This is a community-generated profile. If you would like to claim it, please .
MAP Pharmaceuticals Funding
$50M
11 round
MAP Pharmaceuticals is active in the following markets / industries: biotechnology, medical and pharmaceuticals. The company has secured funding across 1 rounds, totaling in an amount of $50M. Their most recent funding was raised on March 28, 2007.
Funding Rounds
Investors of MAP Pharmaceuticals
Pequot Capital
Alexandria Real Estate Equities
Bay City Capital
Rounds
D
Skyline Ventures
Rounds
D
D.E. Shaw & Co.
Global investment and technology firm
Rounds
D
Perseus
Rounds
D
Pequot Capital Management
Rounds
D
Brookside Capital
Rounds
D
Jay Venkatesan
Investor in @Conor Medsystems, @REVA Medical, @MAP Pharmaceuticals, @Nanosphere, @Targanta.
